Systemic Lupus Erythematosus
- Higher Flare Risk Among Patients With SLE Receiving Maintenance Therapy
- Beta-2 Microglobulin Predicts Lupus Nephritis, SLE Disease Activity
- Hashimoto Thyroiditis Increases Risk for New-Onset Systemic Lupus Erythematosus
- SLE and Diabetes Associated With Higher Risk of Developing ESKD
- Low-Dose Hydroxychloroquine Linked to More Hospitalizations for Lupus Flares
- Patients With SLE Have Lower COVID-19 Vaccine Antibody Responses
- Anifrolumab Linked to Earlier, More Prolonged Responses in SLE
- Predictors of Incident CVD Assessed Among Black Patients With SLE
- Link Between Vitamin D Levels and Clinical and Serologic Factors Studied in SLE
- LN Remission Predicted by Artificial Neural Network
- Improvements in Lab Tests Correlate With Improved Clinical Outcomes in SLE
- Voclosporin Shows Efficacy, Safety for 3 Years in LN
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
